You are here:
liver diseases
#

liver diseases

Get Alerts

Wire

Jul 17, 2014

Staten Island Survivors: Liver transplant brings new life and new fight to 24-year-old Matt Rosiello

It's the day the Huguenot resident received a new liver - just 17 days before his 22 birthday on July 24. It is a matching set with his Matt's Biliary Atresia Fighters - the congenital liver condition that began his life "in combat" - against liver d...

Jul 29, 2014

$1,000-a-pill hepatitis C drug now treatment of choice

A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans. In less than six months, prescriptions for Sovaldi have eclipsed al... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 07, 2014

No practicing on patients: New docs get boot camp

First-day jitters come with any new job but when the work involves pushing needles into strangers' bellies, stitching up gaping wounds or even delivering babies, that debut can be especially nerve-wracking for everyone involved. Brand-new doctors oft... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 19, 2014

Galectin Therapeutics Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 is Efficacious in Preclinical Model of Fatty Liver Disease With Fibrosis - Yahoo Finance

Galectin Therapeutics (GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced today that a preclinical study in a mouse model of NASH (non-alcoholic steatohepatitis, or fatty liver disease) ... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 31, 2014

Health Campaign Focuses on Liver Screening, Testing for Those Born 1945-1965

Health officials are advising that individuals born between 1945 and 1965 ask their medical providers about tests and screenings for liver disease, including certain forms of hepatitis... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 29, 2014

$1,000 pill now hepatitis C treatment of choice

WASHINGTON | A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans. In less than six months, prescriptions for Sovaldi hav... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 29, 2014

Ailing grandmother's dream comes true

Though Lorraine Helton is confined to a hospital bed and has to take multiple medicines to reduce pain and bleeding from chronic liver disease and its complications, she gets a smile on her face and her eyes light up when she talks about her granddau... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 29, 2014

$1,000 Sovaldi now hepatitis treatment of choice

WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects more than 3 million. Even with insurers reluctant to pay, So... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 29, 2014

$1,000 Sovaldi now hepatitis treatment of choice

WASHINGTON (AP) — The price is sky-high, but so is demand. A new $1,000-per-pill drug has become the treatment of choice for Americans with hepatitis C, a liver-wasting disease that affects mo... #California #Connecticut #IMS Health #Gilead Sciences, Inc.

Jul 20, 2014

Thai martial arts action choreographer, film director Panna Ritthikrai dies at 53

Best known as action director and mentor of Thai martial arts action actors Phanom 'Tony Jaa' Yeerum, Panna dies at 53 from liver disease... #California #Connecticut #IMS Health #Gilead Sciences, Inc.